AstraZeneca AB
- A02 - Agentes para el tratamiento de alteraciones causadas por ácidos
- NEXIUM powder for solution for injection 40 mg
- A10 - Antidiabéticos
- BYDUREON DEPOT U?PILDYTAME ?VIRK?TIKLYJE powder and solvent for suspension for injection 2 mg
- BYDUREON DEPOT U?PILDYTAME ?VIRK?TIKLYJE suspension for injection 2 mg
- BYDUREON powder and solvent for suspension for injection 2 mg
- BYETTA solution for injection 10 µg
- BYETTA solution for injection 5 µg
- EBYMECT film-coated tablet 5 mg+1 000 mg
- EBYMECT film-coated tablet 5 mg+850 mg
- EDISTRIDE film-coated tablet 10 mg
- EDISTRIDE film-coated tablet 5 mg
- FORXIGA film-coated tablet 10 mg
- FORXIGA film-coated tablet 5 mg
- KOMBOGLYZE film-coated tablet 1 000 mg+2.5 mg
- KOMBOGLYZE film-coated tablet 850 mg+2.5 mg
- ONGLYZA film-coated tablet 2.5 mg
- ONGLYZA film-coated tablet 5 mg
- QTERN film-coated tablet 5 mg+10 mg
- QTRILMET modified-release tablet 1 000 mg+2.5 mg+5 mg
- QTRILMET modified-release tablet 850 mg+2.5 mg+5 mg
- XIGDUO film-coated tablet 5 mg+1 000 mg
- XIGDUO film-coated tablet 5 mg+850 mg
- B01 - Agentes antitrombóticos
- BRILIQUE film-coated tablet 60 mg
- BRILIQUE film-coated tablet 90 mg
- C08 - Bloqueantes del canal de calcio
- PLENDIL prolonged-release tablet 10 mg
- PLENDIL prolonged-release tablet 2.5 mg
- PLENDIL prolonged-release tablet 5 mg
- C10 - Agentes modificadores de los lípidos
- CRESTOR film-coated tablet 10 mg
- CRESTOR film-coated tablet 20 mg
- CRESTOR film-coated tablet 5 mg
- J06 - Sueros inmunes e inmunoglobulinas
- BEYFORTUS U?PILDYTAME ?VIRK?TE solution for injection 100 mg
- BEYFORTUS U?PILDYTAME ?VIRK?TE solution for injection 50 mg
- EVUSHELD solution for injection 150 mg+150 mg
- SYNAGIS powder and solvent for solution for injection 100 mg
- SYNAGIS powder and solvent for solution for injection 50 mg
- SYNAGIS solution for injection 100 mg/ml
- SYNAGIS solution for injection 50 mg/0.5 ml
- J07 - Vacunas
- FLUENZ TETRA nasal spray, suspension
- PANDEMIC INFLUENZA VACCINE H5N1 ASTRAZENECA nasal spray, suspension
- VAXZEVRIA suspension for injection
- L01 - Antineoplásicos
- CALQUENCE capsule, hard 100 mg
- IMFINZI concentrate for solution for infusion 50 mg/ml
- IRESSA film-coated tablet 250 mg
- KOSELUGO capsule, hard 10 mg
- KOSELUGO capsule, hard 25 mg
- LUMOXITI powder for solution for infusion 1 mg
- LYNPARZA capsule, hard 100 mg
- LYNPARZA capsule, hard 150 mg
- LYNPARZA capsule, hard 50 mg
- TAGRISSO film-coated tablet 40 mg
- TAGRISSO film-coated tablet 80 mg
- L02 - Terapia endocrina
- CASODEX film-coated tablet 150 mg
- CASODEX film-coated tablet 50 mg
- FASLODEX solution for injection 250 mg
- ZOLADEX implant 3.6 mg
- ZOLADEX LA implant 10.8 mg
- L04 - Inmunosupresores
- SAPHNELO concentrate for solution for infusion 300 mg
- R01 - Preparaciones nasales
- RHINOCORT AQUA nasal spray, suspension 32 µg/dose
- RHINOCORT AQUA nasal spray, suspension 64 µg/dose
- R03 - Agentes contra padecimientos obstructivos de las vías respiratorias
- BEVESPI AEROSPHERE pressurised inhalation, suspension 7.2 µg/dose+5 µg/dose
- DALIRESP film-coated tablet 500 µg
- DAXAS film-coated tablet 500 µg
- DAXAS tablet 250 µg
- FASENRA U?PILDYTAME ?VIRK?TE solution for injection 30 mg
- FASENRA U?PILDYTAME ?VIRK?TIKLYJE solution for injection 30 mg
- LIBERTEK film-coated tablet 500 µg
- RILTRAVA AEROSPHERE pressurised inhalation, suspension 5 µg/dose+7.2 µg/dose+160 µg/dose
- SYMBICORT pressurised inhalation, suspension 2.25 µg/dose+80 µg/dose
- SYMBICORT pressurised inhalation, suspension 4.5 µg/dose+160 µg/dose
- SYMBICORT TURBUHALER inhalation powder 4.5 µg/dose+160 µg/dose
- SYMBICORT TURBUHALER inhalation powder 4.5 µg/dose+80 µg/dose
- SYMBICORT TURBUHALER inhalation powder 9 µg/dose+320 µg/dose
- TEZSPIRE PREFILLED SYRINGE solution for injection 210 mg
- TRIXEO AEROSPHERE pressurised inhalation, suspension 5 µg/dose+7.2 µg/dose+160µg/dose
- V03 - Todos los demás preparados terapéuticos
- LOKELMA powder for oral suspension 10 g
- LOKELMA powder for oral suspension 5 g
- ONDEXXYA powder for solution for infusion 200 mg